Last Updated: April 9, 2020 10:43 AM (updates are highlighted in red color)

Jump to a Section

White House

Office of Science and Technology Policy

COVID-19 High Performance Computing (HPC) Consortium

This consortium is a unique private-public effort to bring together federal government, industry, and academic leaders to execute complex computational research programs. Researchers are invited to submit COVID-19 related research proposals to the consortium via this online portal, which will then be reviewed for matching with computing resources from one of the partner institutions. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results.

XSEDE Website

 

National Science Foundation

Important Notice to the Science and Engineering Community

NSF Implementation of OMB Memorandum M-20-17, entitled, “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations.” The purpose of this guidance is to implement flexibilities from specific grant administrative, financial management, and audit requirements. (March 23, 2020)

National Science Foundation/Rapid Response Research (RAPID)

NSF is accepting COVID-19 proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge

Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities. Such activities would be funded by the Computational and Data-Enabled Science and Engineering (CDS&E) program or the Cyberinfrastructure for Sustained Scientific Innovation (CSSI) program. Proposals in response to this DCL and the NSF DCL on COVID-19 (NSF 20-052) may also request the use of NSF-funded advanced computing resources such as Frontera, Stampede2, Bridges, Comet, and JetStream.

 

Health and Human Resources

HHS/Assistant Secretary for Preparedness and Response

Hospital Associations COVID-19 Preparedness and Response Activities

Funding Opportunity : EP-U3R-20-001
Eligible entities include 53 hospital associations in all states. This NOFO will provide targeted awards to 53 hospital associations in all states, the District of Columbia, New York City, and Puerto Rico. Funding will be distributed to hospital associations using a formula specific to COVID-19, which takes into account criteria such as at-risk populations and other vulnerabilities associated with this pandemic (e.g., population density; size of populations with increased risk for mortality from COVID-19, such as older adults and individuals with comorbid health conditions; and health care capacity). Hospital associations will then distribute funds to hospitals and related health care entities within their state or jurisdiction, which may be used to train staff to implement pandemic preparedness plans to respond to COVID-19; procure supplies and equipment (with attention to supply chain shortages); rapidly ramp up infection control and triage training for health care professionals, especially considering growing supply chain shortages; retrofit separate areas to screen and treat large numbers of persons with suspected COVID-19 infections; implement expanded telemedicine and telehealth capabilities, and; increase the numbers of patient care beds to provide surge capacity using temporary structures, such as temporary hospitals that are deployed in a pandemic. (March 24,2020 )

 

HHS/Centers for Disease Control – OSTLTS

Supplemental: Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health

Funding Opportunity Number: CDC-RFA-OT18-18020202SUPP20
CDC announces the availability of supplemental funding for the organizations that were previously awarded funding under Funding Strategy 1 of CDC-RFA-OT18-1802: "Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health" in FY18. 2) Organizations meeting this criteria are eligible to apply for new CIO Project Plans specifically intended to address the current outbreak of COVID-19, and may apply according to the Target Population Category (A,B, or C) and Target Population for which they received initial funding in FY18.3)
Link: grants.gov Search on funding number CDC-RFA-OT18-18020202SUPP20

 

HHS/Centers for Disease Control - OSTLTS

COVID-19 Response Supplement: Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement

Funding Opportunity Number: CDC-RFA-OT18-18030202SUPP20
Eligible Applicants: Native American tribal governments. Emergency supplemental funding to prevent, prepare for, and respond to COVID-19 for the American Indian/Alaska Native (AI/AN) tribal nations and regional AI/AN tribal organizations that were previously awarded funding. (March 24, 2020)

 

Food and Drug Administration/Office of the Chief Scientist (OCS) and Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP)

Drug Development Science Support (U01)

Funding Opportunity Number: FOR-FD-20-010
Announces the intent to release a grant to protect and promote the health of the American public by creating new, applied scientific knowledge, tools, standards and approaches to evaluate products more effectively, predictably and efficiently. NOTE: This is a Forecasted Opportunity. Estimated start date: Sept 01, 2020.

 

HHS/Biomedical Advanced Research and Development Authority (BARDA)

Updated a broad agency announcement (BAA) to solicit proposals for advanced development and licensure of COVID-19 diagnostics, vaccines, or medicines such as therapeutics or antivirals. BARDA will provide funding, as well as expertise and core services to support development projects selected through this BAA. These products include diagnostic tests (assays); vaccines; therapeutics; medications to help regulate or normalize the immune system (immunomodulators); therapeutics targeting lung repair; medicines that prevent infections either before or after exposure to the virus (pre-exposure or post-exposure prophylaxis); respiratory protective devices; and ventilators. BAA-18-100-SOL-00003-Amendment 13 (March 4, 2020)

 

HHS/Biomedical Advanced Research and Development Authority (BARDA)

BARDA opened an easy broad agency announcement, an EZ-BAA, seeking diagnostics that utilize platforms already cleared by the FDA, with a viable plan to meet requirements for the FDA to consider emergency use authorization within 12 weeks.

 

HHS/Office of the Assistant Secretary for Preparedness and Response (ASPR)

Public Health Emergency development of new medical countermeasures

 

HHS/Centers for Disease Control and Prevention (CDC)

Funding to provide resources to state and local jurisdictions in the coronavirus disease 2019 (COVID-19) response. CDC is contacting State Health Officers to move forward with awarding over $560 million to states, localities, territories, and tribes. CDC will use existing networks to reach out to state and local jurisdictions to access this initial funding. Listing of funding to jurisdictions here.

 

HHS/Health Resource and Administration

Frequently Asked Questions for health centers regarding Novel Coronavirus (COVID-19)

 

National Institutes of Health

NIH/National Institute of Allergy and Infectious Diseases (NIAID)

Emergency Supplement Notice of Special Interest (NOSI) Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

Funding Number: NOT-AI-20-034
NIAID is encouraging the submission of applications for Competitive Revisions to active grants. NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. (March 25, 2020)

 

NIH/National Center for Advancing Translational Sciences (NCATS)

Notice of Special Interest (NOSI) : Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need

Funding Number: NOT-TR-20-011
NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. NCATS is soliciting applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337). (March 24, 2020)

 

NIH Small Business Program Office

COVID-19 Update for Small Businesses Webinar

To be held March 30, 2020 at 11am-12am EST. Please join to learn how SBPO is dealing with the COVID-19 pandemic and how your business can engage with the NIH during this time.Register via https://www.surveymonkey.com/r/2YNBCT7

 

NIH/National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of General Medical Sciences (NIGMS)

Administrative Supplementals

Current grantees may be eligible to apply for an administrative supplemental. Contact your program officer to discuss proposed research on SARS-CoV-2/COVID-2019. If it is within the scope of your current grant, an administrative supplement is the best option to obtain additional funding. PA-18-591

 

NIH/National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of General Medical Sciences (NIGMS)

Notice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Notice Number: NOT-AI-20-030
NIAID and NIGMS are collaborating to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV.

 

NIH/National Heart, Lung, and Blood Institute

NHLBI is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Notice Number: NOT-HL-20-757
Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

 

NIH/National Institute on Drug Abuse (NIDA)

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

Notice Number: NOT-DA-20-047
NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. (March 19, 2020)

 

National Institute of Allergy and Infectious Diseases (NIAID)

Coronavirus Resources for Researchers

 

National Institutes of Health/Office of The Director

Given the fact that COVID-19 and associated impacts continue to evolve, applicants and recipients are strongly encouraged to monitor NIH website for updates.

 

General Frequently Asked Questions (FAQs)

Proposal Submission and Award Management Related to COVID-19 NIH intends to publish detailed guidance related to administrative flexibilities and associated FAQs.
Notice Number: NOT-OD-20-083

 

NIH/Fogarty International Center

Coronavirus news, funding and resources for global health researchers

 

NIH Research

Examples of coronavirus research supported by NIH

 

World Health Organization

World scientists on COVID-19 met at the World Health Organization’s Geneva headquarters in February 2020 to assess the current level of knowledge about the new virus, agree on critical research questions that need to be answered urgently, and ways to work together to accelerate and fund priority research that can contribute to curtail this outbreak and prepare for future outbreaks. R&D Blueprint

 

Department of Energy

COVID-19 Rapid Research Response

DOE is soliciting ideas about how the Department and the National Laboratories might contribute resources for science and technology efforts and collaborations. The Department is encouraging the scientific community and others to consider research questions that underpin COVID-19 response and is requesting input on strategic, priority research directions that may be undertaken using DOE user facilities, computational resources, and enabling infrastructure.

Dear Colleague

 

Department of Energy Coronavirus Update:

1. DOE Grant Opportunities 

DOE Announces COVID-19 High Performance Computing Consortium

On March 23, the White House announced a new, unique public-private consortium, spearheaded by the White House Office of Science and Technology Policy (OSTP), the U.S. Department of Energy (DOE), and IBM, including government, industry, and academic leaders to unleash the power of America’s supercomputing resources to combat COVID-19. The launch of the COVID-19 High Performance Computing Consortium will provide COVID-19 researchers with access to the world’s most powerful high performance computing resources that can significantly advance the pace of scientific discovery in the fight to stop the virus. Researchers are invited to submit COVID-19 related research proposals to the consortium via the online portal which will then be reviewed and matched with computing resources from one of the partner institutions. An expert panel of top scientists and computing researchers will work with proposers to quickly assess the public health benefit of the work and coordinate the allocation of the group’s powerful computing assets.

Department of Energy Announces New Funding to Train Emergency Response and Building Professionals (Not Coronavirus related)

Today, the U.S. Department of Energy announced $4.5 million in funding for training programs for professionals who interact with distributed energy resources, including solar energy systems, storage systems, “smart” building technologies, and electric vehicles. These professionals include those that lead the nation’s emergency response and resilience planning, including firefighters, first responders, and safety officials.

Read more here: https://www.eenews.net/energywire/2020/04/06/stories/1062798751

 

2. Energy Policy

Stimulus priorities shift as pandemic worsens

In an appearance on CNBC on Friday, Pelosi signaled that items included in the broader infrastructure bill may need to wait for an even later COVID-19 stimulus bill. "While I'm very much in favor of doing some of the things that we need to do to meet the needs — clean water, more broadband and the rest of that — that may have to be for a bill beyond this," she said. The shift in tone in recent days suggests the next stimulus will revive the controversies of the first three COVID-19 emergency bills, including individual direct payments, unemployment benefits, more funds for health care and medical supplies, and oversight of the just-enacted $2 trillion package — the largest in U.S. history.

Read more here: https://www.eenews.net/eedaily/2020/04/06/stories/1062798813

Trump's oil meeting: The aftermath, details and drama

President Trump, who met last week at the White House with oil company executives and lawmakers, said over the weekend he'd wield tariffs if needed to protect the oil industry, which is reeling from a global glut in supply. "If I have to do tariffs on oil coming from outside, or if I have to do something to protect thousands and tens of thousands of energy workers and our great companies that produce all these jobs, I'll do whatever I have to do," Trump said at a Saturday White House briefing, warning that low prices "are going to hurt a lot of jobs." A day earlier, however, Trump suggested he was unlikely to impose tariffs, which are fiercely opposed by the big oil companies, which want little government intervention. "These are great companies, and they'll figure it out; it's a free market," Trump said after the White House meeting Friday with the chief executives of Chevron Corp., Exxon Mobil Corp. and others. "We'll figure it out." Then yesterday, Trump reiterated that he'd "absolutely" consider tariffs if oil prices remain in the cellar, arguing that it would save "tens of thousands of jobs." But he added that he didn't think he would have to, because the current price war between Russia and Saudi Arabia is "very bad for them."

Read more here: https://www.eenews.net/energywire/2020/04/06/stories/1062798751

A warning sign? N.Y. lockdown jolts electricity demand

New York City — ground zero for the COVID-19 pandemic in the United States — is entering its third week of a citywide shutdown that has pushed electricity demand down sharply, flashing what researchers say are warning signals to utilities in other American urban centers. An E&E News analysis of data from the state's grid operator, the New York Independent System Operator, reveals average hourly electricity load or demand in New York's five boroughs for the five-day workweek beginning March 23 was 4,808 megawatts, a 12% drop compared with the same period last year. 

Read more here: https://www.eenews.net/energywire/2020/04/06/stories/1062798303

 

3. DOE ongoing work on Coronavirus:

https://www.energy.gov/articles/how-doe-and-our-labs-are-combating-covid-19

Understanding the Novel Coronavirus’ Structure:

Scientists need to know precisely how the novel coronavirus is built to better understand how it infects other cells, how it is transmitted, and what drugs it might be vulnerable to. Argonne National Laboratory (ANL) researchers and their colleagues, for example, have determined the atomic structure of viral proteins that appear to be important inside an infected cell, are involved in virus replication, or function during virus assembly. These so-called non-structural proteins (they are not part of the virus particle structure itself) are principal drug targets. The proteins were expressed, purified and crystallized at ANL’s Advanced Protein Characterization Facility, and data were collected at the Structural Biology Center and other beamlines of the Advanced Photon Source, which provides ultra-bright, high-energy X-rays that illuminate the structure and composition of very small entities like the virus that traditional microscopes can’t. 

Modeling Epidemics:

Many of the National Laboratories have experts who can plot COVID-19 infections and develop models for how and where it is spreading.  Los Alamos National Laboratory, for example, develops mathematical and computational models for infectious diseases, and in the past crafted epidemiological models for Smallpox, Anthrax, HIV, Ebola, and Influenza, among others. The lab has also worked on investigating the role of internet data streams on monitoring emergent behavior during outbreaks and forecasting infectious diseases.  They are putting their expertise to work modeling how COVID-19 infections spread, and how people behave during outbreaks.

Screening Drugs:

Over the decades, hundreds of thousands of chemical compounds have been tested for effectiveness against many other kinds of coronaviruses and viruses in general.  The computing speed of DOE’s fastest and most powerful supercomputers and its laboratories’ deep expertise in artificial intelligence is being used to rapidly screen known chemical compounds that might affect this novel coronavirus.  Researchers at Oak Ridge National Laboratory announced that they have used Summit, the world’s fastest and smartest supercomputer, to screen more than 8,000 drug compounds for 77 that have potential for use in the fight against COVID-19.

Coordinating and Expanding Access for Coronavirus Research:

DOE is making its unique, world-class user facilities available to the scientific community on a priority basis for COVID-19 work. The DOE X-ray light sources are coordinating priority access to their structural biology resources.

 

4. Scientific and Technical Information Available via OSTI.GOV

DOE-funded Scientific and Technical Information (STI), which includes Journal Articles, Technical Reports, Software, Datasets, etc., is made available via OSTI.GOV. To support national and worldwide research efforts, OSTI.GOV has provided a custom search for Coronavirus and related topics: OSTI.GOV Coronavirus and Related Biological Research Results

Additionally, the following search terms are provided for your convenience; to further refine your search you can select from the “full text” links (i.e., record metadata and the research object are available) or “citation only” (i.e., record only includes access to bibliographic metadata).

https://science.osti.gov/DOE-Resources-Supporting-Coronavirus-Research

 

Department of Defense

Defense Logistics Agency (DLA) Troop Support Clothing & Textiles Directorate

Request for Information for PPE in response to COVID-19

Notice ID: SPE1C1-20-R-COVID19
DLA is conducting market research to determine industry capabilities for providing Personal Protective Equipment (PPE) against viral contamination, specifically COVID-19. This is a Request for Information only and not a solicitation for award. (March 20, 2020)

 

Updated: Medical Technology Enterprise Consortium released Request for Project Proposals (RPP) for prototypes of medical and information technologies to combat Covid-19.

Notice ID: MTEC-solicitation-COVID-19
FOCUS AREA: Therapeutic(s) that can treat COVID-19. Treatments with potential application to the prevention of COVID-19 infection are desired. Therapeutics that can be administered in a non-hospital environment are desired. (March 25, 2020)

 

Defense/Army Medical Research Acquisition Activity (USAMRAA)

USAMRAA’s COVID-19 FAQs

This notice addresses general questions associated with proposal submission and award management that may arise in relation to COVID-19. These FAQs will be updated here as more information becomes available.

 

Department of Homeland Security

Homeland Security/Science and Technology Directorate

Crucial Research to Mitigate COVID-19

Press Release - (March 25, 2020)

 

TSA Industry Assistance with COVID-19

Notice ID: 2020-TSA-IndustryNotice
In the current climate TSA appreciates industry offering to assist the Agency in response to COVID-19. Please submit your offering to the Contracting and Procurement office point of contact, Evelyn S. Tyndell at This email address is being protected from spambots. You need JavaScript enabled to view it.to ensure appropriate handling.

 

Department of Justice

DOJ/Office of Community Oriented Policing Services Office (COPS)

COPS has extended the solicitation deadline for several open grant programs due to the potential impact of jurisdictional emergency responses to COVID-19 that may cause reasonable delays for applicants. For detailed individual program information, see the grants page.

 

DOJ/Office of Justice Programs

OJP announced that solicitations with application due dates before April 1st will have a 2 week extension for submission. OJP Grantee Update #1 COVID-19 Impacts

 

Department of Justice (DOJ) Updates:

Department of Justice Issues Business Review Letter to Medical Supplies Distributors Supporting Project Airbridge Under Expedited Procedure for COVID-19 Pandemic Response

The U.S. Department of Justice announced today that it will not challenge collaborative efforts of McKesson Corporation, Owens & Minor, Inc., Cardinal Health, Inc., Medline Industries, Inc., and Henry Schein, Inc. (together “Medical Supplies Distributors”) to expedite and increase manufacturing, sourcing, and distribution of personal-protective equipment (“PPE”) and coronavirus-treatment-related medication. These collaborative efforts are part of an emergency response developed and led by the Federal Emergency Management Agency (FEMA) and the U.S. Department of Health and Human Services (HHS) to address supply needs arising from the COVID-19 pandemic.

 

OFFICE OF JUSTICE PROGRAMS ANNOUNCES NEARLY $70 MILLION IN GRANTS AVAILABLE TO SUPPORT PRISONERS’ SUCCESSFUL REENTRY INTO THEIR COMMUNITIES

The Office of Justice Programs today announced that almost $70 million in grant funding is available to help communities address public safety by supporting successful reentry of adult and juvenile offenders into their communities.

“Our nation is facing difficult public safety challenges that demand strong and immediate action. The high rate of recidivism poses a dire threat to community safety and is being met with a robust response by this Administration,” said OJP Principal Deputy Assistant Attorney General Katharine T. Sullivan. “The Department of Justice is front and center in the fight to meet this persistent challenge. OJP is making historic amounts of grant funding available to ensure that our communities have access to innovative and diverse solutions.”

Department of Commerce

COVID-19 Department of Commerce Update:

National Institute for Standards and Technology (NIST) Cybersecurity Funding Opportunity

On Monday, April 6th, The National Institute for Standards and Technology (NIST) announced funding on behalf of the National Initiative for Cybersecurity Education (NICE) for the NICE K12 Cybersecurity Education Outreach Program. NIST is soliciting applications from U.S.-located, non-Federal entities to assist NICE in its outreach efforts to build a K12 community that inspires cybersecurity career awareness with students in elementary school, stimulates cybersecurity career exploration in middle school, and enables cybersecurity career preparedness in high school.

NICE seeks to provide financial assistance to an organization engaged with stakeholders involved in helping K12 students pursue cybersecurity education and work-based learning opportunities through a year-round communication and engagement strategy that culminates in the annual NICE K12 Cybersecurity Education Conference.

The deadline to apply is Monday, June 1, 2020,and the full grant announcement can be found here.